Hemato Oncology Testing Market Size, Share & Trends Report

Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer Type (Leukemia, Lymphoma), By Technology, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68039-174-2
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Hemato Oncology Testing Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Leukemia
  - Acute Myeloid Leukemia (AML)
  - Acute Lymphocytic Leukemia (ALL)
  - Chronic Lymphocytic Leukemia
  - Chronic Myeloid Leukemia
- Lymphoma
  - Non-Hodgkin Lymphoma
  - Hodgkin Lymphoma
- Myeloproliferative Neoplasms
  - Polycythemia vera (PV)
  - Essential thrombocythemia (ET)
  - Myelofibrosis (MF)
- Other Cancers
Hemato Oncology Testing Product Outlook (Revenue, USD Million, 2018 - 2030)
- Assay Kits and Reagents
- Services
Hemato Oncology Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)
- PCR
  - Real-time qPCR
  - Digital PCR
- IHC
- NGS
- Cytogenetics
- Other Technologies
Hemato Oncology Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Academic & Research Institutes
- Others
Hemato Oncology Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Hemato Oncology Testing Market, By Cancer Type
    - Leukemia
      - Acute Myeloid Leukemia (AML)
      - Acute Lymphocytic Leukemia (ALL)
      - Chronic Lymphocytic Leukemia
      - Chronic Myeloid Leukemia
    - Lymphoma
      - Non-Hodgkin Lymphoma
      - Hodgkin Lymphoma
    - Myeloproliferative Neoplasms
      - Polycythemia Vera (PV)
      - Essential Thrombocythemia (ET)
      - Myelofibrosis (MF)
    - Other Cancers
  - North America Hemato Oncology Testing Market, By Product
    - Assay Kits and Reagents
    - Services
  - North America Hemato Oncology Testing Market, By Technology
    - PCR
      - Real-time qPCR
      - Digital PCR
    - IHC
    - NGS
    - Cytogenetics
    - Other Technologies
  - North America Hemato Oncology Testing Market, By End-use
    - Hospitals
    - Academic & Research Institutes
    - Others
  - U.S.
    - U.S. Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - U.S. Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - U.S. Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - U.S. Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Other
  - Canada
    - Canada Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Canada Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Canada Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Canada Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
- Europe
  - Europe Hemato Oncology Testing Market, By Cancer Type
    - Leukemia
      - Acute Myeloid Leukemia (AML)
      - Acute Lymphocytic Leukemia (ALL)
      - Chronic Lymphocytic Leukemia
      - Chronic Myeloid Leukemia
    - Lymphoma
      - Non-Hodgkin Lymphoma
      - Hodgkin Lymphoma
    - Myeloproliferative Neoplasms
      - Polycythemia Vera (PV)
      - Essential Thrombocythemia (ET)
      - Myelofibrosis (MF)
    - Other Cancers
  - Europe Hemato Oncology Testing Market, By Product
    - Assay Kits and Reagents
    - Services
  - Europe Hemato Oncology Testing Market, By Technology
    - PCR
      - Real-time qPCR
      - Digital PCR
    - IHC
    - NGS
    - Cytogenetics
    - Other Technologies
  - Europe Hemato Oncology Testing Market, By End-use
    - Hospitals
    - Academic & Research Institutes
    - Others
  - U.K.
    - U.K. Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - U.K. Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - U.K. Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - U.K. Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Germany
    - Germany Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Germany Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Germany Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Germany Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - France
    - France Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - France Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - France Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - France Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Italy
    - Italy Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Italy Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Italy Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Italy Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Spain
    - Spain Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Spain Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Spain Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Spain Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Russia
    - Russia Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Russia Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Russia Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Russia Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Sweden
    - Sweden Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Sweden Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Sweden Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Sweden Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Denmark
    - Denmark Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Denmark Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Denmark Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Denmark Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Norway
    - Norway Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Norway Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Norway Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Norway Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
- Asia Pacific
  - Asia Pacific Hemato Oncology Testing Market, By Cancer Type
    - Leukemia
      - Acute Myeloid Leukemia (AML)
      - Acute Lymphocytic Leukemia (ALL)
      - Chronic Lymphocytic Leukemia
      - Chronic Myeloid Leukemia
    - Lymphoma
      - Non-Hodgkin Lymphoma
      - Hodgkin Lymphoma
    - Myeloproliferative Neoplasms
      - Polycythemia Vera (PV)
      - Essential Thrombocythemia (ET)
      - Myelofibrosis (MF)
    - Other Cancers
  - Asia Pacific Hemato Oncology Testing Market, By Product
    - Assay Kits and Reagents
    - Services
  - Asia Pacific Hemato Oncology Testing Market, By Technology
    - PCR
      - Real-time qPCR
      - Digital PCR
    - IHC
    - NGS
    - Cytogenetics
    - Other Technologies
  - Asia Pacific Hemato Oncology Testing Market, By End-use
    - Hospitals
    - Academic & Research Institutes
    - Others
  - Japan
    - Japan Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Japan Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Japan Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Japan Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - China
    - China Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - China Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - China Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - China Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - India
    - India Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - India Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - India Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - India Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - South Korea
    - South Korea Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - South Korea Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - South Korea Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - South Korea Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Australia
    - Australia Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Australia Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Australia Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Australia Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Singapore
    - Singapore Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Singapore Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Singapore Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Singapore Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Thailand
    - Thailand Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Thailand Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Thailand Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Thailand Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
- Latin America
  - Latin America Hemato Oncology Testing Market, By Cancer Type
    - Leukemia
      - Acute Myeloid Leukemia (AML)
      - Acute Lymphocytic Leukemia (ALL)
      - Chronic Lymphocytic Leukemia
      - Chronic Myeloid Leukemia
    - Lymphoma
      - Non-Hodgkin Lymphoma
      - Hodgkin Lymphoma
    - Myeloproliferative Neoplasms
      - Polycythemia Vera (PV)
      - Essential Thrombocythemia (ET)
      - Myelofibrosis (MF)
    - Other Cancers
  - Latin America Hemato Oncology Testing Market, By Product
    - Assay Kits and Reagents
    - Services
  - Latin America Hemato Oncology Testing Market, By Technology
    - PCR
      - Real-time qPCR
      - Digital PCR
    - IHC
    - NGS
    - Cytogenetics
    - Other Technologies
  - Latin America Hemato Oncology Testing Market, By End-use
    - Hospitals
    - Academic & Research Institutes
    - Others
  - Brazil
    - Brazil Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Brazil Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Brazil Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Brazil Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Mexico
    - Mexico Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Mexico Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Mexico Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Mexico Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Argentina
    - Argentina Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Argentina Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Argentina Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Argentina Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
- MEA
  - MEA Hemato Oncology Testing Market, By Cancer Type
    - Leukemia
      - Acute Myeloid Leukemia (AML)
      - Acute Lymphocytic Leukemia (ALL)
      - Chronic Lymphocytic Leukemia
      - Chronic Myeloid Leukemia
    - Lymphoma
      - Non-Hodgkin Lymphoma
      - Hodgkin Lymphoma
    - Myeloproliferative Neoplasms
      - Polycythemia Vera (PV)
      - Essential Thrombocythemia (ET)
      - Myelofibrosis (MF)
    - Other Cancers
  - MEA Hemato Oncology Testing Market, By Product
    - Assay Kits and Reagents
    - Services
  - MEA Hemato Oncology Testing Market, By Technology
    - PCR
      - Real-time qPCR
      - Digital PCR
    - IHC
    - NGS
    - Cytogenetics
    - Other Technologies
  - MEA Hemato Oncology Testing Market, By End-use
    - Hospitals
    - Academic & Research Institutes
    - Others
  - Saudi Arabia
    - Saudi Arabia Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Saudi Arabia Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Saudi Arabia Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Saudi Arabia Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - South Africa
    - South Africa Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - South Africa Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - South Africa Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - South Africa Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - UAE
    - UAE Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - UAE Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - UAE Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - UAE Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others
  - Kuwait
    - Kuwait Hemato Oncology Testing Market, By Cancer Type
      - Leukemia
        
        Acute Myeloid Leukemia (AML)
        
        Acute Lymphocytic Leukemia (ALL)
        
        Chronic Lymphocytic Leukemia
        
        Chronic Myeloid Leukemia
      - Lymphoma
        
        Non-Hodgkin Lymphoma
        
        Hodgkin Lymphoma
      - Myeloproliferative Neoplasms
        
        Polycythemia Vera (PV)
        
        Essential Thrombocythemia (ET)
        
        Myelofibrosis (MF)
      - Other Cancers
    - Kuwait Hemato Oncology Testing Market, By Product
      - Assay Kits and Reagents
      - Services
    - Kuwait Hemato Oncology Testing Market, By Technology
      - PCR
        
        Real-time qPCR
        
        Digital PCR
      - IHC
      - NGS
      - Cytogenetics
      - Other Technologies
    - Kuwait Hemato Oncology Testing Market, By End-use
      - Hospitals
      - Academic & Research Institutes
      - Others

Hemato Oncology Testing Market Dynamics

Driver: Increasing Prevalence Of Lymphoma & Myeloma

Growth in the market is expected to be driven over the forecast period by the increasing incidence of myeloma and lymphoma. The American Cancer Society estimates that non-Hodgkin lymphoma (NHL) represents approximately 4% of all cancer cases in the United States, making it one of the most prevalent cancer types there. NHL ranks eighth in terms of incidence among all malignancies in the United States, accounting for 4.3% of cases, according to the National Institutes of Health (NIH). Moreover, the majority of individuals diagnosed with NHL are 67 years old on average. The NHL incidence has been declining for the past ten years, according to NIH estimates based on statistical models, at a rate of 0.9% annually. Furthermore, the mortality rate declined by an average of 5.4% per year from 2014 to 2018. Timely diagnosis and appropriate treatment approaches are key contributors to the decrease in incidence and fatality rates. According to Cancer Research UK, the incidence of NHL is rising, with 14,176 new cases identified each year in the UK. NHL is the sixth most frequent malignancy in the region, accounting for 4% of all new occurrences in 2016-2018. Since the early 1990s, the UK has seen a 38% increase in NHL cases.

Growing Demand For Personalized Therapy

Since treatment plans in personalized medicine are based on data gathered using a holistic approach, the field offers a paradigm shift in diagnosis and care delivery. The growth of the Human Genome Project in the field of genomics and the proliferation of sequencing technologies, particularly Next-Generation Sequencing (NGS), as a result of growing sequencing costs are anticipated to drive the industry. By providing information about a patient's genetic composition and how they react to medications, next-generation sequencing (NGS) technology advances the field of precision medicine. In addition, a few other factors anticipated to propel market expansion include rising healthcare spending levels that necessitate the need for efficient cancer diagnostic techniques, the rising incidence of cancer, and the rising use of combination biomarkers for diagnostics. Major companies in the personalized medicine market are participating in several precision medicine investment programmes. Furthermore, firms that offer molecular decision support systems are merging genomic data with clinical data to close gaps in precision medical practice.

Restraint: Unfavorable Reimbursement Scenario

The fact that major medical insurers do not reimburse diagnostic products is one of the main disadvantages of using them. To cut costs, diagnostic companies are typically forced to wait until a considerable level of product acceptance has been reached. A primary element compromising reimbursement plans is regulatory authority approval, including FDA and CE approval. A major obstacle that producers of diagnostic medical devices must overcome is the insurers' universal coverage in patient care and physician institutional settings. Medical device reimbursement rates are typically determined by procedure and device type rather than by the technology within the device. As a result, most diagnostic gadgets are not reimbursed anywhere in the world. The funding picture for novel diagnostic devices is substantially more complex because they use advanced technology and are far more expensive than existing medical diagnostic devices. Novel oncology diagnostic screening devices present technological, scientific, financial, and regulatory challenges, with payment being one of the most pressing concerns. Because innovative diagnostics approval takes a significantly longer period of time, the majority of businesses are investing in the development of companion diagnostics, which are approved in conjunction with therapeutic medications.

What Does This Report Include?

This section will provide insights into the contents included in this hemato oncology testing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Hemato oncology testing market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Hemato oncology testing market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.